(Q36138929)

English

A randomised phase II study of sialyl-Tn and DETOX-B adjuvant with or without cyclophosphamide pretreatment for the active specific immunotherapy of breast cancer

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

A randomised phase II study of sialyl-Tn and DETOX-B adjuvant with or without cyclophosphamide pretreatment for the active specific immunotherapy of breast cancer (English)

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

1 reference

based on heuristic

inferred from title

author name string

D W Miles

1

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

K E Towlson

2

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

R Graham

3

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

M Reddish

4

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

B M Longenecker

5

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

J Taylor-Papadimitriou

6

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

R D Rubens

7

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

language of work or name

0 references

publication date

1 October 1996

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

British Journal of Cancer

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

74

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

8

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

1292-1296

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

Cyclophosphamide-sensitive and cyclophosphamide-resistant suppressor cells in the immune response to alloantigens

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2075933

2 October 2017

Augmentation of specific immune response against a syngeneic SV40-induced sarcoma in mice by depletion of suppressor T cells with cyclophosphamide

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2075933

2 October 2017

Expression of sialyl-Tn predicts the effect of adjuvant chemotherapy in node-positive breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2075933

2 July 2018

Expression of sialyl-Tn in gastric cancer: correlation with known prognostic factors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2075933

2 July 2018

Active specific immunotherapy for melanoma: phase I trial of allogeneic lysates and a novel adjuvant

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2075933

2 July 2018

Active specific immunotherapy of a murine mammary adenocarcinoma using a synthetic tumor-associated glycoconjugate.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2075933

2 July 2018

Sialosyl-Tn. A novel mucin antigen associated with prognosis in colorectal cancer patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2075933

2 July 2018

Lack of effect of cyclophosphamide on the immunogenicity of a melanoma antigen vaccine

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2075933

2 July 2018

Effect of cyclophosphamide on the immune response of BALB/c mice bearing an immunoglobulin M plasmacytoma (TEPC-183).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2075933

23 September 2018

Immunization of breast cancer patients using a synthetic sialyl-Tn glycoconjugate plus Detox adjuvant

1 reference

https://pubmed.ncbi.nlm.nih.gov/8883420

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Potentiation of human cell-mediated and humoral immunity by low-dose cyclophosphamide

1 reference

https://pubmed.ncbi.nlm.nih.gov/8883420

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Active immunotherapy of human melanoma exploiting the immunopotentiating effects of cyclophosphamide

1 reference

https://pubmed.ncbi.nlm.nih.gov/8883420

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tumor regression in monoclonal antibody-treated patients correlates with the presence of anti-idiotype-reactive T lymphocytes

1 reference

https://pubmed.ncbi.nlm.nih.gov/8883420

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Induction of alpha-N-acetylgalactosamine-O-serine/threonine (Tn) antigen-mediated cellular immune response for active immunotherapy in mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/8883420

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serum sialyl Tn as an independent predictor of poor prognosis in patients with epithelial ovarian cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/8883420

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Active Immunization of Human Ovarian Cancer Patients Against a Common Carcinoma (Thomsen-Friedenreich) Determinant Using a Synthetic Carbohydrate Antigen

1 reference

https://pubmed.ncbi.nlm.nih.gov/8883420

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1038/BJC.1996.532

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

12 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36138929&oldid=2198259904"